Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

about

Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts.Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase.

P2860

Q33581698-179AFD83-549E-4B51-9A52-21A2AE46CDEB Q41660900-91503960-9DA5-4CA6-A0D2-6AC31209ECA3

P2860

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

Item

http://www.wikidata.org/entity/Q54704593

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@en

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@nl

type

Item

label

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@en

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@nl

prefLabel

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@en

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@nl

P1476

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

@en

P2093

Jos Ruiter

http://www.w3.org/2001/XMLSchema#string

Lodewijk IJlst

http://www.w3.org/2001/XMLSchema#string

Margarida F B Silva

http://www.w3.org/2001/XMLSchema#string

Marinus Duran

http://www.w3.org/2001/XMLSchema#string

Paula B M Luís

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic evidence for the expression of ATP- and GTP-specific succinyl-CoA synthetases in multicellular eucaryotes

Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion

Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options

Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations

Expression of two succinyl-CoA synthetases with different nucleotide specificities in mammalian tissues

Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase

Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites.

The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein.

The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion.

Deoxyribonucleotides and disorders of mitochondrial DNA integrity.

P2888

s10545-013-9657-4

P304

353-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10545-013-9657-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Isabel Tavares de Almeida

Ronald J A Wanders

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24154984

http://www.w3.org/2001/XMLSchema#string

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

about

P2860

P2860

Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698